Delivery Order SPE2DB20D7059-SPE2DB25FQMH7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.93 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 MG patches (8-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,136.83 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 mg patches (8-count) with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and represents a specific product delivery under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for COMBIPATCH 0.05-0.14 mg patches in a quantity of 8 units. This is a firm fixed price delivery order with a ceiling value of $1,743.72 and an ultimate completion date of August 14, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's...
- This federal contract award, valued at $1,007.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a medical product, with a performance period ending on July 2, 2025. The contract is not designated as a set-aside and is a Firm Fixed Price type. Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of COMBIPATCH TDBW 8S pharmaceutical products. This competitively awarded, non-set-aside delivery order has a ceiling value of $2,534.45 with firm fixed pricing and is scheduled for completion by July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this order. The delivery order is issued...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a $1,373.04 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical. This order is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which is not designated as a set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 5,231.17 in Combipatch transdermal patches (0.05-0.14 mg), with an ultimate completion date of August 15, 2025. This competitive award, issued on August 14, 2025, carries a firm fixed price structure and involves no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) has awarded a $2,550.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the federal government. This contract is for the provision of 4564984416 COMBIPATCH 0.05-0.14 MG PTCH 8S, a medical product, with an ultimate completion date of June 25, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.82 firm fixed-price delivery order is for the supply of "COMBIPATCH 0.05-0.14 MG PTCH 8S", a pharmaceutical product, with a period of performance through March 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMBIPATCH 0.05-0.14 MG PTCH 8S, a pharmaceutical product, with an ultimate completion date of May 30, 2025 and a ceiling value of $1,494.22. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQMH7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,791.52 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count units). This is a firm fixed price, non-set-aside contract with a completion date of July 31, 2025, and performance occurring at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value and extends through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The contract demonstrates AmerisourceBergen Drug Corp's capability to meet federal procurement requirements through open competition and serves customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/30/25 |